CUI Shaomin,ZHANG Huairui,ZHANG Xinghan,et al.Experience in the syndrome differentiation and treatment of skin adverse reactions related to tumor targeted therapy[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(09):1071-1074.
CUI Shaomin,ZHANG Huairui,ZHANG Xinghan,et al.Experience in the syndrome differentiation and treatment of skin adverse reactions related to tumor targeted therapy[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(09):1071-1074. DOI: 10.16025/j.1674-1307.2024.09.024.
Experience in the syndrome differentiation and treatment of skin adverse reactions related to tumor targeted therapy
BEDARD PL, HYMAN DM, DAVIDS MS, et al. Small molecules, big impact: 20 years of targeted therapy in oncology[J]. Lancet, 2020,395(10229):1078-1088.
MCFARLANE T, REHMAN N, WANG K, et al. Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment[J]. Ann Palliat Med, 2020,9(3):1296-1306.
PENG Y, LI Q, ZHANG J, et al. Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors[J]. Biosci Trends, 2019,12(6):537-552.